Editor's Note Many people have reportedly been experiencing cold-like symptoms this winter, which have often been attributed to “some bug”; however, there’s a strong chance these symptoms were due to a new surge of COVID-19, Wired January 10 reports. There’s a new, large global surge in daily COVID-19 infections currently…

Read More

Editor's Note A new study suggests that someone's initial exposure to a specific COVID-19 variant shows some influence to their immune response to subsequent variants of SARS-CoV-2, the virus responsible for COVID-19, the University of Cambridge October 6 reports. The research, published by Science on October 6 and titled "Mapping…

Read More

Editor's Note This new study from the Cleveland Clinic found that use of COVID-19 antiviral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduces risk of hospitalization and death in high-risk patients with mild disease, even against Omicron subvariants. The findings were published in JAMA Network on September 21. The study included…

Read More

Editor's Note With COVID-19 rates rising again, and winter cold and flu season around the corner, it is time for healthcare personnel to get a COVID-19 booster shot to help protect against illness–and recommend patients to do the same. In a September 2023 TIME Magazine article, doctors weigh in on…

Read More

Editor's Note The COVID-19 Omicron subvariant EG.5 is now the dominant variant in the US, replacing Arcturus XBB.1.16, according to the August 4 US News & World Report. EG.5 accounts for more than 17% of new COVID-19 cases in the US in the past 2 weeks, and it is increasing…

Read More